Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia, Chronic, Chronic-Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03075969
What this trial is testing

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 337
Early research (Phase 1)Study completedNCT00049686
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Vion Pharmaceuticals
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT00210119
What this trial is testing

Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response

Who this might be right for
Myeloid Leukemia, Chronic
Institut Bergonié 19
Testing effectiveness (Phase 2)Study completedNCT01092741
What this trial is testing

Late Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT01772420
What this trial is testing

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Who this might be right for
Adult Myelodysplastic SyndromeAnemiaChronic Myelomonocytic Leukemia
Albert Einstein College of Medicine 52
Testing effectiveness (Phase 2)Study completedNCT00012259
What this trial is testing

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Shire 31
Very early researchUnknownNCT04156256
What this trial is testing

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
iCell Gene Therapeutics 20
Testing effectiveness (Phase 2)Looking for participantsNCT04588922
What this trial is testing

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Who this might be right for
Hematologic Malignancies
Sellas Life Sciences Group 160
Testing effectiveness (Phase 2)UnknownNCT00328237
What this trial is testing

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more
Colorado Blood Cancer Institute 20
Early research (Phase 1)Study completedNCT00111683
What this trial is testing

MK0457 in Patients With Leukemia (0457-003)

Who this might be right for
Chronic Myelogenous Leukemia in Blast CrisisLymphocytic Leukemia, B Cell, AcuteMyelodysplastic Syndromes+1 more
Merck Sharp & Dohme LLC 28
Early research (Phase 1)Active Not RecruitingNCT02091245
What this trial is testing

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Who this might be right for
Relapsed Acute Lymphoblastic Leukemia (ALL)Refractory Acute Lymphoblastic Leukemia (ALL)Relapsed Acute Myelogenous Leukemia (AML)+6 more
Dana-Farber Cancer Institute 16
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Testing effectiveness (Phase 2)Study completedNCT02208037
What this trial is testing

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 279
Testing effectiveness (Phase 2)Looking for participantsNCT03934372
What this trial is testing

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAccelerated Phase Chronic Myeloid LeukemiaBlast Phase Chronic Myeloid Leukemia+6 more
Incyte Biosciences International Sàrl 70
Testing effectiveness (Phase 2)Study completedNCT00005618
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00019656
What this trial is testing

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00015951
What this trial is testing

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaMyelodysplastic Syndromes
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00042003
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Large-scale testing (Phase 3)Study completedNCT03268954
What this trial is testing

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromeLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute
Takeda 454
Next Page